Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials

Patrick Oellers,1,2 Dilraj S Grewal,1,2 Sharon Fekrat1,2 1Duke Eye Center, Duke University Medical Center, 2Surgical Service, Durham Veterans Affairs Medical Center, Durham, NC, USA Abstract: For years, the standard of care for branch-retinal-vein-occlusion-associated macular edema was initial obs...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Oellers P, Grewal DS, Fekrat S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	branch retinal vein occlusion BRVO macular edema cystoid macular Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/3c92590f7ceb47eeadd0763d90e059b6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3c92590f7ceb47eeadd0763d90e059b6
record_format	dspace
spelling	oai:doaj.org-article:3c92590f7ceb47eeadd0763d90e059b62021-12-02T02:27:51ZRole of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials1177-5483https://doaj.org/article/3c92590f7ceb47eeadd0763d90e059b62016-03-01T00:00:00Zhttps://www.dovepress.com/role-of-aflibercept-for-macular-edema-following-branch-retinal-vein-oc-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Patrick Oellers,1,2 Dilraj S Grewal,1,2 Sharon Fekrat1,2 1Duke Eye Center, Duke University Medical Center, 2Surgical Service, Durham Veterans Affairs Medical Center, Durham, NC, USA Abstract: For years, the standard of care for branch-retinal-vein-occlusion-associated macular edema was initial observation followed by grid-pattern laser photocoagulation for persistent edema. Newer pharmacologic options have revolutionized the management of branch-retinal-vein-occlusion-associated macular edema, and the visual outcomes of these eyes are better than ever. However, a variety of available treatment options including intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factor agents have established novel challenges with regard to appropriate drug selection. This review summarizes the available clinical studies with special emphasis on the comparison of intravitreal aflibercept with ranibizumab, bevacizumab, and steroid agents. Keywords: branch retinal vein occlusion, BRVO, macular edema, cystoid macular edema, grid-pattern laser photocoagulation, triamcinolone, dexamethasone implant, ranibizumab, bevacizumab, pegaptanib, anti-vascular endothelial growth factorOellers PGrewal DSFekrat SDove Medical Pressarticlebranch retinal vein occlusionBRVOmacular edemacystoid macularOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2016, Iss Issue 1, Pp 411-418 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	branch retinal vein occlusion BRVO macular edema cystoid macular Ophthalmology RE1-994
spellingShingle	branch retinal vein occlusion BRVO macular edema cystoid macular Ophthalmology RE1-994 Oellers P Grewal DS Fekrat S Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
description	Patrick Oellers,1,2 Dilraj S Grewal,1,2 Sharon Fekrat1,2 1Duke Eye Center, Duke University Medical Center, 2Surgical Service, Durham Veterans Affairs Medical Center, Durham, NC, USA Abstract: For years, the standard of care for branch-retinal-vein-occlusion-associated macular edema was initial observation followed by grid-pattern laser photocoagulation for persistent edema. Newer pharmacologic options have revolutionized the management of branch-retinal-vein-occlusion-associated macular edema, and the visual outcomes of these eyes are better than ever. However, a variety of available treatment options including intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factor agents have established novel challenges with regard to appropriate drug selection. This review summarizes the available clinical studies with special emphasis on the comparison of intravitreal aflibercept with ranibizumab, bevacizumab, and steroid agents. Keywords: branch retinal vein occlusion, BRVO, macular edema, cystoid macular edema, grid-pattern laser photocoagulation, triamcinolone, dexamethasone implant, ranibizumab, bevacizumab, pegaptanib, anti-vascular endothelial growth factor
format	article
author	Oellers P Grewal DS Fekrat S
author_facet	Oellers P Grewal DS Fekrat S
author_sort	Oellers P
title	Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
title_short	Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
title_full	Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
title_fullStr	Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
title_full_unstemmed	Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
title_sort	role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/3c92590f7ceb47eeadd0763d90e059b6
work_keys_str_mv	AT oellersp roleofafliberceptformacularedemafollowingbranchretinalveinocclusioncomparisonofclinicaltrials AT grewalds roleofafliberceptformacularedemafollowingbranchretinalveinocclusioncomparisonofclinicaltrials AT fekrats roleofafliberceptformacularedemafollowingbranchretinalveinocclusioncomparisonofclinicaltrials
_version_	1718402460967501824

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials

Ejemplares similares